Biotech Values

[genisi]

>African-Americans represent 16 percent of the patients enrolled and 7 percent of patients in the study are cirrhotic.<

Just to note that patients with cirrhosis are probably somewhat harder to treat (presumably because absorption of the drug is lower). Also African-Americans usually show lower SVR rates.
[There were no cirrhotic patients in Prove1 and 2 studies.]